β-lapachone reduces cell viability, migration, and epithelial–mesenchymal transition in mammary tumor spheroids - Takeaways - DentalSpire

β-lapachone reduces cell viability, migration, and epithelial–mesenchymal transition in mammary tumor spheroids

  • By

  • Laura Lacerda Coelho

  • Matheus Menezes Vianna

  • Debora Moraes da Silva

  • Beatriz Matheus de Souza Gonzaga

  • Roberto Rodrigues Ferreira

  • Claudia Mara Lara Melo Coutinho

  • Fatima Cristina Mendes Magalhães

  • Edmilson José Maria

  • Rodrigo Rodrigues de Oliveira

  • Pedro Paulo de Abreu Manso

  • Marcelo Alex de Carvalho

  • Fernando Regla Vargas

  • Luciana Ribeiro Garzoni

  • November 26, 2025

  • 0 min

Share

  • 1

    Breast cancer is the most common cancer in women, with metastasis contributing to poor prognosis and high mortality rates.

  • 2

    β-lapachone, derived from Tabebuia avellanedae, shows promise as an anticancer agent with effects on various tumors, including breast cancer.

  • 3

    The study utilized a 3D model of mammary tumor spheroids to evaluate the cytotoxic and antimetastatic effects of β-lapachone.

  • 4

    Results indicated that β-lapachone significantly reduced cell viability, migration, and inhibited epithelial–mesenchymal transition in mammary tumor spheroids.

  • 5

    The findings support the potential of β-lapachone as a therapeutic agent for improving outcomes in breast cancer treatment.

Original Source(s)

Related Content